0001493152-21-022863.txt : 20210915
0001493152-21-022863.hdr.sgml : 20210915
20210915215017
ACCESSION NUMBER: 0001493152-21-022863
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210913
FILED AS OF DATE: 20210915
DATE AS OF CHANGE: 20210915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jenusaitis Matthew
CENTRAL INDEX KEY: 0001357864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38325
FILM NUMBER: 211256846
MAIL ADDRESS:
STREET 1: 2 GOODYEAR
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc.
CENTRAL INDEX KEY: 0001661053
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330936180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-261-2900
MAIL ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
ownership.xml
X0306
4
2021-09-13
0
0001661053
Hancock Jaffe Laboratories, Inc.
HIJI
0001357864
Jenusaitis Matthew
70 DOPPLER
IRVINE
CA
92618
1
0
0
0
Common Stock
2021-09-13
4
M
0
1042
A
5884
D
Restricted Stock Units
2021-09-13
4
M
0
1042
0
D
Common Stock
1042
2084
D
Each restricted stock unit ("RSU") converts into one share of common stock of Hancock Jaffe Laboratories, Inc.
On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021
/s/ Matthew Jenusaitis
2021-09-15